Order Article Reprints

Zaninelli S, Panna S, Tettamanti S, Melita G, Doni A, D’Autilia F, Valgardsdottir R, Gotti E, Rambaldi A, Golay J, et al. Functional Activity of Cytokine-Induced Killer Cells Enhanced by CAR-CD19 Modification or by Soluble Bispecific Antibody Blinatumomab. Antibodies. 2024; 13(3):71. https://doi.org/10.3390/antib13030071

Zaninelli, Silvia, Silvia Panna, Sarah Tettamanti, Giusi Melita, Andrea Doni, Francesca D’Autilia, Rut Valgardsdottir, Elisa Gotti, Alessandro Rambaldi, Josée Golay, and et al. 2024. "Functional Activity of Cytokine-Induced Killer Cells Enhanced by CAR-CD19 Modification or by Soluble Bispecific Antibody Blinatumomab" Antibodies 13, no. 3: 71. https://doi.org/10.3390/antib13030071

Zaninelli, S., Panna, S., Tettamanti, S., Melita, G., Doni, A., D’Autilia, F., Valgardsdottir, R., Gotti, E., Rambaldi, A., Golay, J., & Introna, M. (2024). Functional Activity of Cytokine-Induced Killer Cells Enhanced by CAR-CD19 Modification or by Soluble Bispecific Antibody Blinatumomab. Antibodies, 13(3), 71. https://doi.org/10.3390/antib13030071